| SC 13G/A | 2016-02-11 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 18,316,097 | 8.5% | EDGAR |
| SC 13G/A | 2016-02-10 | BlackRock Inc. | Edwards Lifesciences Corp | 14,046,404 | 6.5% | EDGAR |
| SC 13G/A | 2015-04-10 | Capital World Investors | Edwards Lifesciences Corp | - | 0.0% | EDGAR |
| SC 13G/A | 2015-02-17 | GENERATION INVESTMENT MANAGEMENT LLP | Edwards Lifesciences Corp | 4,189,138 | 3.9% | EDGAR |
| SC 13G/A | 2015-02-13 | GROWTH FUND OF AMERICA | Edwards Lifesciences Corp | 5,122,000 | 4.7% | EDGAR |
| SC 13G/A | 2015-02-13 | Capital Research Global Investors | Edwards Lifesciences Corp | 8,813,400 | 8.2% | EDGAR |
| SC 13G/A | 2015-02-13 | Capital World Investors | Edwards Lifesciences Corp | 5,439,400 | 5.0% | EDGAR |
| SC 13G/A | 2015-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Edwards Lifesciences Corp | 3,587,752 | 3.4% | EDGAR |
| SC 13G/A | 2015-02-11 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 8,665,085 | 8.1% | EDGAR |
| SC 13G/A | 2015-02-09 | BlackRock Inc. | Edwards Lifesciences Corp | 7,452,307 | 7.0% | EDGAR |
| SC 13G | 2014-09-18 | GENERATION INVESTMENT MANAGEMENT LLP | Edwards Lifesciences Corp | 5,529,612 | 5.2% | EDGAR |
| SC 13G/A | 2014-08-08 | Capital World Investors | Edwards Lifesciences Corp | 6,536,022 | 6.1% | EDGAR |
| SC 13G | 2014-02-14 | WELLINGTON MANAGEMENT CO LLP | Edwards Lifesciences Corp | 5,564,500 | 5.1% | EDGAR |
| SC 13G/A | 2014-02-13 | GROWTH FUND OF AMERICA | Edwards Lifesciences Corp | 8,982,700 | 8.2% | EDGAR |
| SC 13G/A | 2014-02-13 | PRICE T ROWE ASSOCIATES INC /MD/ | Edwards Lifesciences Corp | 351,935 | 0.3% | EDGAR |
| SC 13G/A | 2014-02-13 | Capital Research Global Investors | Edwards Lifesciences Corp | 13,738,600 | 12.6% | EDGAR |
| SC 13G/A | 2014-02-13 | Capital World Investors | Edwards Lifesciences Corp | 13,339,400 | 12.1% | EDGAR |
| SC 13G/A | 2014-02-12 | VANGUARD GROUP INC | Edwards Lifesciences Corp | 7,361,439 | 6.7% | EDGAR |
| SC 13G/A | 2014-02-10 | BlackRock Inc. | Edwards Lifesciences Corp | 7,346,857 | 6.7% | EDGAR |
| SC 13G/A | 2013-05-10 | Capital World Investors | Edwards Lifesciences Corp | 13,975,400 | 12.2% | EDGAR |